Metabolic Drivers of Ocular Damage Insulin Resistance, GLP-1 Pathways, Muscle Health, and Antioxidants in Disease and Prevent
Tracking # 20-1388579
$99999.00
There are no ratings for this course
Learn moreCourse overview
This course explores metabolic syndrome and hyperinsulinemia as primary drivers of metabolic dysfunction and their role in contributing to ocular and systemic disease. Emphasis is placed on insulin resistance, metabolic pathway disruption, and the role of muscle and mitochondrial health. The course also highlights behavior modification strategies and GLP1-based therapies as tools for metabolic intervention, with oxidative stress and antioxidant status presented as contributing factors. Attendees will gain practical insight into identifying metabolic risk and incorporating objective assessment into patient care.
Subject areas
This course counts toward the state boards and subject areas below.